[HTML][HTML] Regulation of PD-L1: a novel role of pro-survival signalling in cancer

J Chen, CC Jiang, L Jin, XD Zhang - Annals of oncology, 2016 - Elsevier
Evasion of immune system is a hallmark of cancer, which enables cancer cells to escape the
attack from immune cells. Cancer cells can express many immune inhibitory signalling …

Human papillomaviruses as infectious agents in gynecological cancers. Oncogenic properties of viral proteins

DA Haręża, JR Wilczyński, E Paradowska - International journal of …, 2022 - mdpi.com
Human papillomaviruses (HPVs), which belong to the Papillomaviridae family, constitute a
group of small nonenveloped double-stranded DNA viruses. HPV has a small genome that …

Viral oncology: molecular biology and pathogenesis

UN Mui, CT Haley, SK Tyring - Journal of clinical medicine, 2017 - mdpi.com
Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …

Role of the JAK/STAT pathway in cervical cancer: its relationship with HPV E6/E7 oncoproteins

A Gutiérrez-Hoya, I Soto-Cruz - Cells, 2020 - mdpi.com
The janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling
pathway is associated with the regulation of essential cellular mechanisms, such as …

Effects of intestinal microbial–elaborated butyrate on oncogenic signaling pathways

J Chen, KN Zhao, L Vitetta - Nutrients, 2019 - mdpi.com
The intestinal microbiota is well known to have multiple benefits on human health, including
cancer prevention and treatment. The effects are partially mediated by microbiota-produced …

RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

SM Gupta, J Mania-Pramanik - Journal of biomedical science, 2019 - Springer
Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of
mortality in developing countries. Persistent infection with high-risk human papillomavirus …

[HTML][HTML] Role of microRNAs in chemoresistance

P Magee, L Shi, M Garofalo - Annals of translational medicine, 2015 - ncbi.nlm.nih.gov
Drug resistance is a major problem in the treatment of cancer patients. Resistance can
develop after prolonged cycles of chemotherapy or can be present intrinsically in the patient …

Anticancer effects of nutraceuticals in the Mediterranean diet: an epigenetic diet model

R Divella, A Daniele, E Savino… - Cancer Genomics & …, 2020 - cgp.iiarjournals.org
Epidemiological and clinical studies support the association between nutrition and
development or progression of different malignancies such as colon, breast, and prostate …

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

P Vici, L Pizzuti, L Mariani, G Zampa… - Expert review of …, 2016 - Taylor & Francis
Human papillomavirus (HPV) is widely known as a cause of cervical cancer (CC) and
cervical intraepithelial neoplasia (CIN). HPVs related to cancer express two main …

[HTML][HTML] Insights into therapy resistance in cervical cancer

IA George, R Chauhan, RE Dhawale, R Iyer… - Advances in Cancer …, 2022 - Elsevier
Abstract Treatment failure is one of the main hurdles in treating cervical cancer, despite
significant breakthroughs in both conventional and targeted therapy. The one-year survival …